Nexviazyme is a 2nd generation Enzyme Replacement Therapy (ERT) for Pompe disease. Genzyme Corporation has put an application in to Medsafe NZ for assessment and approval.
Then we need to cross our fingers that PHARMAC will approve it for funding!
Nexviazyme is a 2nd generation Enzyme Replacement Therapy (ERT) for Pompe disease. Genzyme Corporation has put an application in to Medsafe NZ for assessment and approval.
Then we need to cross our fingers that PHARMAC will approve it for funding!